Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 22 | 2019 | 422 | 3.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2019 | 1462 | 2.400 |
Why?
|
| Clinical Competence | 5 | 2019 | 338 | 1.490 |
Why?
|
| Blood Glucose Self-Monitoring | 6 | 2013 | 28 | 1.430 |
Why?
|
| Family Practice | 5 | 2020 | 49 | 1.410 |
Why?
|
| Curriculum | 3 | 2018 | 211 | 1.180 |
Why?
|
| Blood Glucose | 8 | 2013 | 494 | 1.150 |
Why?
|
| Health Literacy | 4 | 2018 | 29 | 1.100 |
Why?
|
| Patient Education as Topic | 6 | 2018 | 265 | 1.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2019 | 360 | 1.070 |
Why?
|
| Attitude to Health | 3 | 2020 | 163 | 0.990 |
Why?
|
| Self Care | 8 | 2016 | 144 | 0.980 |
Why?
|
| European Continental Ancestry Group | 11 | 2014 | 1163 | 0.940 |
Why?
|
| Humans | 57 | 2021 | 32779 | 0.910 |
Why?
|
| Hypertension | 4 | 2017 | 976 | 0.900 |
Why?
|
| Primary Health Care | 4 | 2021 | 231 | 0.880 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 352 | 0.870 |
Why?
|
| Female | 41 | 2020 | 20249 | 0.870 |
Why?
|
| Middle Aged | 32 | 2021 | 12115 | 0.760 |
Why?
|
| Hypoglycemic Agents | 4 | 2010 | 180 | 0.740 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 72 | 0.740 |
Why?
|
| Male | 36 | 2020 | 19624 | 0.710 |
Why?
|
| Naloxone | 1 | 2021 | 29 | 0.680 |
Why?
|
| Students, Medical | 3 | 2019 | 132 | 0.680 |
Why?
|
| Mental Health Services | 1 | 2020 | 31 | 0.650 |
Why?
|
| Ethnic Groups | 5 | 2016 | 474 | 0.640 |
Why?
|
| Aged | 28 | 2020 | 10534 | 0.640 |
Why?
|
| Obstetrics | 1 | 2019 | 28 | 0.610 |
Why?
|
| Pharmacists | 2 | 2017 | 20 | 0.610 |
Why?
|
| Islam | 1 | 2019 | 2 | 0.600 |
Why?
|
| Arabs | 1 | 2019 | 4 | 0.600 |
Why?
|
| African Americans | 9 | 2014 | 1424 | 0.600 |
Why?
|
| Maternal Health Services | 1 | 2019 | 9 | 0.600 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 26 | 0.600 |
Why?
|
| Refugees | 1 | 2019 | 9 | 0.600 |
Why?
|
| Patient Compliance | 5 | 2013 | 218 | 0.590 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 239 | 0.590 |
Why?
|
| Health Behavior | 5 | 2014 | 234 | 0.580 |
Why?
|
| Adult | 16 | 2020 | 9547 | 0.580 |
Why?
|
| Neuralgia | 1 | 2019 | 47 | 0.580 |
Why?
|
| Group Processes | 1 | 2018 | 15 | 0.550 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 1140 | 0.550 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2017 | 2 | 0.540 |
Why?
|
| Diabetes, Gestational | 2 | 2009 | 27 | 0.540 |
Why?
|
| Education, Medical, Continuing | 2 | 2008 | 53 | 0.530 |
Why?
|
| Aged, 80 and over | 16 | 2020 | 4032 | 0.520 |
Why?
|
| North Carolina | 12 | 2019 | 1546 | 0.520 |
Why?
|
| Program Development | 1 | 2017 | 96 | 0.510 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 252 | 0.510 |
Why?
|
| Insulin | 2 | 2010 | 367 | 0.490 |
Why?
|
| Prenatal Care | 1 | 2016 | 54 | 0.490 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 215 | 0.490 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 195 | 0.490 |
Why?
|
| Anticoagulants | 1 | 2017 | 136 | 0.490 |
Why?
|
| Patient Participation | 1 | 2016 | 87 | 0.480 |
Why?
|
| Cross-Sectional Studies | 12 | 2014 | 1572 | 0.470 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 412 | 0.460 |
Why?
|
| Blood Pressure | 5 | 2017 | 861 | 0.450 |
Why?
|
| Diabetic Angiopathies | 2 | 2013 | 145 | 0.440 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 15 | 0.420 |
Why?
|
| Rural Population | 8 | 2014 | 286 | 0.420 |
Why?
|
| Students, Health Occupations | 1 | 2013 | 7 | 0.390 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2018 | 79 | 0.380 |
Why?
|
| Dietary Fats | 1 | 2013 | 109 | 0.380 |
Why?
|
| Counseling | 1 | 2013 | 98 | 0.380 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2011 | 3 | 0.370 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 175 | 0.360 |
Why?
|
| Pregnancy | 4 | 2019 | 981 | 0.330 |
Why?
|
| Cohort Studies | 6 | 2020 | 1844 | 0.330 |
Why?
|
| Hyperglycemia | 1 | 2010 | 81 | 0.320 |
Why?
|
| United States | 9 | 2014 | 4108 | 0.310 |
Why?
|
| Risk Factors | 11 | 2017 | 3974 | 0.310 |
Why?
|
| Academic Medical Centers | 2 | 2008 | 162 | 0.300 |
Why?
|
| Research Design | 2 | 2008 | 331 | 0.290 |
Why?
|
| Qualitative Research | 5 | 2019 | 199 | 0.290 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2008 | 5 | 0.280 |
Why?
|
| Disease Management | 3 | 2014 | 128 | 0.280 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 23 | 0.280 |
Why?
|
| Minority Groups | 3 | 2016 | 86 | 0.280 |
Why?
|
| Faculty, Medical | 1 | 2008 | 77 | 0.260 |
Why?
|
| Ambulatory Care | 2 | 2018 | 109 | 0.250 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 130 | 0.250 |
Why?
|
| Coronary Disease | 1 | 2007 | 214 | 0.250 |
Why?
|
| Indians, North American | 6 | 2013 | 110 | 0.250 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 56 | 0.240 |
Why?
|
| Hispanic Americans | 3 | 2007 | 930 | 0.230 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 171 | 0.220 |
Why?
|
| Mass Screening | 2 | 2009 | 268 | 0.220 |
Why?
|
| Obesity | 3 | 2016 | 1152 | 0.210 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 187 | 0.210 |
Why?
|
| Exercise | 3 | 2016 | 679 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 436 | 0.200 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 767 | 0.180 |
Why?
|
| Absorptiometry, Photon | 1 | 2002 | 136 | 0.180 |
Why?
|
| Osteoporosis | 1 | 2002 | 71 | 0.170 |
Why?
|
| Harm Reduction | 1 | 2021 | 15 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2021 | 43 | 0.170 |
Why?
|
| Age Factors | 4 | 2013 | 1197 | 0.160 |
Why?
|
| Serbia | 1 | 2019 | 4 | 0.160 |
Why?
|
| Physician Assistants | 2 | 2013 | 38 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2021 | 2327 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 22 | 0.160 |
Why?
|
| Risk Reduction Behavior | 2 | 2016 | 125 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 531 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 166 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 252 | 0.140 |
Why?
|
| Education, Medical | 1 | 2019 | 70 | 0.140 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 138 | 0.140 |
Why?
|
| Clinical Clerkship | 1 | 2018 | 41 | 0.130 |
Why?
|
| South Carolina | 1 | 2017 | 32 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 881 | 0.130 |
Why?
|
| Tennessee | 1 | 2017 | 107 | 0.130 |
Why?
|
| Certification | 1 | 2017 | 28 | 0.130 |
Why?
|
| Frail Elderly | 1 | 2017 | 71 | 0.130 |
Why?
|
| Group Practice | 1 | 2016 | 3 | 0.130 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 115 | 0.130 |
Why?
|
| Models, Organizational | 1 | 2016 | 15 | 0.130 |
Why?
|
| Adolescent | 2 | 2020 | 3627 | 0.130 |
Why?
|
| Communication | 1 | 2018 | 141 | 0.130 |
Why?
|
| Young Adult | 2 | 2020 | 2730 | 0.120 |
Why?
|
| Sex Factors | 3 | 2013 | 675 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 622 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2016 | 101 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 307 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 779 | 0.120 |
Why?
|
| African Continental Ancestry Group | 2 | 2007 | 363 | 0.120 |
Why?
|
| Patient Selection | 1 | 2016 | 281 | 0.110 |
Why?
|
| Culture | 2 | 2012 | 39 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2016 | 182 | 0.110 |
Why?
|
| Linear Models | 2 | 2013 | 445 | 0.110 |
Why?
|
| Diabetes Complications | 2 | 2013 | 182 | 0.110 |
Why?
|
| Executive Function | 2 | 2012 | 56 | 0.100 |
Why?
|
| Fear | 1 | 2013 | 50 | 0.100 |
Why?
|
| Trust | 1 | 2013 | 45 | 0.100 |
Why?
|
| Faculty | 1 | 2013 | 15 | 0.100 |
Why?
|
| Patient Simulation | 1 | 2013 | 29 | 0.100 |
Why?
|
| Feedback | 1 | 2013 | 42 | 0.100 |
Why?
|
| Energy Intake | 1 | 2013 | 128 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 112 | 0.090 |
Why?
|
| Cognition | 2 | 2013 | 551 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 181 | 0.090 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 57 | 0.090 |
Why?
|
| Social Control, Informal | 1 | 2012 | 8 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 63 | 0.090 |
Why?
|
| Glycemic Index | 1 | 2011 | 14 | 0.090 |
Why?
|
| Body Weight | 1 | 2013 | 301 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 80 | 0.090 |
Why?
|
| Narration | 1 | 2011 | 18 | 0.090 |
Why?
|
| Interviews as Topic | 4 | 2013 | 272 | 0.090 |
Why?
|
| Insurance Coverage | 1 | 2011 | 80 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 327 | 0.080 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 9 | 0.080 |
Why?
|
| Professional Role | 1 | 2010 | 19 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 49 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 292 | 0.080 |
Why?
|
| Documentation | 1 | 2010 | 47 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 908 | 0.080 |
Why?
|
| Asian Americans | 2 | 2007 | 95 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2010 | 86 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 265 | 0.070 |
Why?
|
| Staff Development | 1 | 2008 | 16 | 0.070 |
Why?
|
| Geography | 1 | 2007 | 35 | 0.070 |
Why?
|
| Models, Educational | 1 | 2007 | 18 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 77 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 407 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2007 | 60 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 105 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 488 | 0.070 |
Why?
|
| Information Systems | 1 | 2006 | 9 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 150 | 0.060 |
Why?
|
| Logistic Models | 2 | 2012 | 783 | 0.060 |
Why?
|
| Insulin, Long-Acting | 1 | 2006 | 3 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 467 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 91 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3437 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 19 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2005 | 60 | 0.060 |
Why?
|
| Quality of Life | 2 | 2016 | 961 | 0.050 |
Why?
|
| Lipids | 1 | 2005 | 229 | 0.050 |
Why?
|
| Minerals | 1 | 2003 | 15 | 0.050 |
Why?
|
| Medicare | 1 | 2004 | 213 | 0.050 |
Why?
|
| Child | 1 | 2009 | 2471 | 0.050 |
Why?
|
| Vitamins | 1 | 2003 | 73 | 0.050 |
Why?
|
| Heel | 1 | 2002 | 6 | 0.050 |
Why?
|
| Alendronate | 1 | 2002 | 11 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2003 | 187 | 0.040 |
Why?
|
| Bone Density | 1 | 2002 | 203 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 1460 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2012 | 388 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 186 | 0.040 |
Why?
|
| Depression | 2 | 2012 | 448 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2005 | 3700 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2019 | 226 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 34 | 0.030 |
Why?
|
| Community Health Services | 1 | 2016 | 58 | 0.030 |
Why?
|
| Poverty | 1 | 2016 | 116 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 194 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 263 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 486 | 0.030 |
Why?
|
| Medicine | 1 | 2013 | 40 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 457 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 46 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 764 | 0.020 |
Why?
|
| Family Relations | 1 | 2012 | 18 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 95 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 25 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2013 | 171 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2012 | 105 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 75 | 0.020 |
Why?
|
| Holistic Health | 1 | 2011 | 7 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 2180 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 288 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 183 | 0.020 |
Why?
|
| Health Status | 1 | 2013 | 402 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 1238 | 0.020 |
Why?
|
| Social Support | 1 | 2012 | 183 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 77 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 236 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 138 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 938 | 0.010 |
Why?
|
| Southeastern United States | 1 | 2005 | 79 | 0.010 |
Why?
|
| Morbidity | 1 | 2005 | 101 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 413 | 0.010 |
Why?
|
| Infection Control | 1 | 2003 | 29 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1002 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 78 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 525 | 0.010 |
Why?
|